Literature DB >> 26077330

Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Paco E Bravo1, Hong-Chang Luo2, Iraklis Pozios2, Stefan L Zimmerman2, Celia Pamela Corona-Villalobos2, Lars Sorensen2, Ihab R Kamel2, David A Bluemke3, Richard L Wahl2, M Roselle Abraham2, Theodore P Abraham2.   

Abstract

AIMS: To investigate whether hypertrophic cardiomyopathy (HCM) patients with late gadolinium enhancement (LGE) confined to the right ventricular insertion points (RVIP) differ phenotypically from patients without LGE or intramural LGE in the left ventricle (LV). METHODS AND
RESULTS: Sixty-two HCM patients underwent cardiac magnetic resonance for quantification of LGE (% LV mass) and were classified as group (i) no-LGE (n = 18), group (ii) LGE-RVIP (n = 19), and group (iii) intramural LGE (n = 25). All patients also underwent vasodilator N-13 ammonia PET to quantify myocardial blood flow (MBF) and myocardial flow reserve (MFR), and echocardiography to measure longitudinal LV strain. LGE extent (17 ± 11% vs. 4 ± 4% vs. 0%; P < 0.001) and LV thickness (21.7 ± 3.4 vs. 18.8 ± 3.9 vs. 16.3 ± 2.8 mm; P < 0.001) were significantly greater in group 3, intermediate in group 2, and lower in group 1. In contrast, stress MBF (1.62 ± 0.44 vs. 1.90 ± 0.37 vs. 2.22 ± 0.48 mL/min/g; P < 0.001); MFR (1.92 ± 0.47 vs. 2.15 ± 0.52 vs. 2.71 ± 0.52; P < 0.001), and longitudinal LV strain (-11.4 ± 3.8 vs. -12.6 ± 3.2 vs. -14.4 ± 4.1%; P = 0.04) were lower in group 3, intermediate in group 2, and higher in group 1.
CONCLUSIONS: From an imaging viewpoint, patients with LGE confined to only the RVIP appear to represent an intermediate-stage phenotype between patients with no LGE and intramural LGE in the LV. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  CMR; LGE; RV insertion points

Mesh:

Substances:

Year:  2015        PMID: 26077330      PMCID: PMC4750506          DOI: 10.1093/ehjci/jev154

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  34 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

2.  Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.

Authors:  Caitlin J Harrigan; Dana C Peters; C Michael Gibson; Barry J Maron; Warren J Manning; Martin S Maron; Evan Appelbaum
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

3.  Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Evan Appelbaum; Caitlin J Harrigan; Jacki Buros; C Michael Gibson; Connie Hanna; John R Lesser; James E Udelson; Warren J Manning; Barry J Maron
Journal:  Circ Heart Fail       Date:  2008-06-23       Impact factor: 8.790

4.  Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.

Authors:  Paco E Bravo; Stefan L Zimmerman; Hong-Chang Luo; Iraklis Pozios; Mahadevan Rajaram; Aurélio Pinheiro; Charles Steenbergen; Ihab R Kamel; Richard L Wahl; David A Bluemke; Frank M Bengel; M Roselle Abraham; Theodore P Abraham
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-15       Impact factor: 7.792

Review 5.  The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.

Authors:  Albert A Hagège; Patrick Bruneval; Robert A Levine; Michel Desnos; Hany Neamatalla; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2011-09-10       Impact factor: 4.132

6.  Morphological determinants of echocardiographic patterns of mitral valve systolic anterior motion in obstructive hypertrophic cardiomyopathy.

Authors:  H G Klues; W C Roberts; B J Maron
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

7.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

8.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  James C C Moon; Emma Reed; Mary N Sheppard; Andrew G Elkington; Siew Yen Ho; Margaret Burke; Mario Petrou; Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

9.  Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes.

Authors:  Ryan K Kaple; Ross T Murphy; Linda M DiPaola; Penny L Houghtaling; Harry M Lever; Bruce W Lytle; Eugene H Blackstone; Nicholas G Smedira
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

10.  Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis.

Authors:  Elena Biagini; Massimiliano Lorenzini; Iacopo Olivotto; Guido Rocchi; Luigi Lovato; Francesco Lai; Stefania Rosmini; Chiara Pazzi; Ferdinando Pasquale; Maria Letizia Bacchi Reggiani; Rossella Fattori; Claudio Rapezzi
Journal:  BMJ Open       Date:  2012-10-11       Impact factor: 2.692

View more
  7 in total

1.  Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts.

Authors:  Chrysanthos Grigoratos; Adriana Pantano; Maria Meschisi; Raffaella Gaeta; Lamia Ait-Ali; Andrea Barison; Giancarlo Todiere; Pierluigi Festa; Gianfranco Sinagra; Giovanni Donato Aquaro
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-06       Impact factor: 2.357

2.  Potential Value of Native T1 Mapping in Symptomatic Adults with Congenital Heart Disease: A Preliminary Study of 3.0 Tesla Cardiac Magnetic Resonance Imaging.

Authors:  Yumi Shiina; Kei Inai; Kota Taniguchi; Tatsunori Takahashi; Michinobu Nagao
Journal:  Pediatr Cardiol       Date:  2019-10-25       Impact factor: 1.655

3.  Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease.

Authors:  Manvir Kaur Hayer; Anna Marie Price; Boyang Liu; Shanat Baig; Charles Joseph Ferro; Jonathan Nicholas Townend; Richard Paul Steeds; Nicola Catherine Edwards
Journal:  Am J Cardiol       Date:  2017-12-11       Impact factor: 2.778

Review 4.  Major Clinical Issues in Hypertrophic Cardiomyopathy.

Authors:  Hyung-Kwan Kim; Sang Chol Lee; Hyun-Jung Lee; Jihoon Kim; Sung-A Chang; Yong-Jin Kim
Journal:  Korean Circ J       Date:  2022-08       Impact factor: 3.101

5.  Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study.

Authors:  Jeong-Eun Yi; Junbeom Park; Hye-Jeong Lee; Dong Geum Shin; Yookyung Kim; Minsuk Kim; Kihwan Kwon; Wook Bum Pyun; Young Jin Kim; Boyoung Joung
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

Review 6.  Phase analysis of gated PET in the evaluation of mechanical ventricular synchrony: A narrative overview.

Authors:  Luis Eduardo Juarez-Orozco; Andrea Monroy-Gonzalez; Niek H J Prakken; Walter Noordzij; Juhani Knuuti; Robert A deKemp; Riemer H J A Slart
Journal:  J Nucl Cardiol       Date:  2019-03-04       Impact factor: 5.952

7.  Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis.

Authors:  Lebogang Mokotedi; Frederic S Michel; Conrad Mogane; Monica Gomes; Angela J Woodiwiss; Gavin R Norton; Aletta M E Millen
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.